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Abstract Amputation of the lower limb is one of the most
feared diabetic complications. It is associated with loss of
mobility and a poor quality of life. Amputations result in
high economic burden for the healthcare system. The finan-
cial cost is also high for patients and their families, partic-
ularly in countries that lack a comprehensive health service
and/or have a low income. Losing a leg frequently implies
financial ruin for a whole family in these countries; there-
fore, a reduction in diabetes-related amputations is a major
global priority. Marked geographical variation in amputa-
tion rates has been reported within specific regions of an
individual country and between countries. A coordinated
healthcare system with a multidisciplinary approach is es-
sential if the number of amputations is to be reduced. This
commentary discusses how studies on the variation in am-
putation rates can help to identify barriers in the access or
delivery of care with the aim of reducing the burden of
diabetic foot disease.
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In this issue of Diabetologia Holman and co-workers de-
scribe a worrisome variation in the recorded incidence of
lower extremity amputations in England [1]. Based on data
reported by all National Health Service (NHS) hospitals, the
authors calculated the number of minor (below-ankle) and
major (above-ankle) amputations per year in adults and
combined this with data from other sources to estimate the
amputation rate per 1,000 person-years in both diabetic and
non-diabetic subjects. The incidence of total amputations
(minor plus major) varied eightfold across Primary Care
Trusts in both patients with diabetes (range, 0.64–5.25 per
1,000 person-years) and patients without diabetes (0.03–
0.24 per 1,000 person-years). These important data are in
line with several other studies that reported marked differ-
ences in amputation rate within specific regions of a country
and between countries [2, 3].
Amputations are usually preceded by a foot ulcer and the
most important factors predicting a poor outcome of these
ulcers are the extent of tissue loss, infection, peripheral
arterial disease (PAD) and co-morbidity [2–4]. The reasons
for a major amputation are limited; the most frequent rea-
sons are critical limb ischaemia with rest pain or progressive
infection in a leg that cannot be successfully revascularised
[5]. Sometimes an immediate amputation is performed be-
cause of life-threatening infection or infection with massive
tissue loss. In addition, a minor amputation is frequently
performed for a forefoot abscess, osteomyelitis or gangrene
of a toe [5]. If other options are exhausted or undesirable,
amputation can therefore be a treatment and not a failure.
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factors that determine the amputation rate and pinpointing
why it varies so markedly in England and elsewhere is a
challenge [2] (Fig. 1). Part of the variability reported in the
paper by Holman et al [1] could be explained by ethnic
differences [6] but, owing to the study design, there is no
information on disease severity or management. In the pro-
spective European Study Group on Diabetes and the Lower
Extremity (Eurodiale) study, which was performed in 1,232
diabetic patients with a new foot ulcer from all over Europe,
the number of major amputations was too low (5%) to
analyse, but the minor amputation rate varied markedly
between the participating centres, from 2% to 33% [7]. As
all patients underwent a comprehensive evaluation, a dis-
ease severity score could be calculated for each patient and a
large part of the variation could be explained by differences
in disease severity (r00.75). Amputation rate should there-
fore not be used as a quality indicator in diabetic foot
disease, unless it can be corrected for the relevant character-
istics of the patient, the leg and the foot.
The management of a diabetic foot ulcer requires a mul-
tidisciplinary approach, including revascularisation and sur-
gical procedures as well as treatment of infection, oedema,
pain, metabolic disturbances, malnutrition, co-morbidities,
meticulous wound care and biomechanical offloading [5]. A
coordinated system of support for both patients and carers is
necessary to successfully implement these strategies, and if
such an integrated approach is used, 45–85% of all ampu-
tations can be avoided [8–10]. The creation of a national
network of specialised diabetic foot teams that are accessi-
ble to every patient should be the first priority for the
prevention of amputations. England is a country with a
single nationalised healthcare system, therefore the wide
geographical variation in amputation rate cannot be
explained by differences in reimbursement, availability of
resources or access to care but point to differences in the
organisation or delivery of care, as suggested by Holman et
al [1]. Treatment delay because of underestimation of dis-
ease severity, unawareness of the potential dangers of a foot
ulcer, or not recognising that it is a sign of multi-organ
disease, by both the patient and the doctor can lead to a
poor outcome. Initial treatment by physicians is frequently
empirical, involving dressings and antibiotics. Only when
the ulcer does not heal or deteriorates are patients referred
for systematic management [11]. Up to 50% of the patients
with a diabetic foot ulcer have PAD and infected ischaemic
ulcers in particular have a poor prognosis; spreading of
infection can be extremely rapid and ‘time is tissue’ in these
ulcers [5]. In one study, late referral was associated with
larger ulcers that had a poorer prognosis [3]. In Sweden, the
amputation rate was lower in a region where direct referral
by district nurses to a specialised centre was possible com-
pared with a region where patients could only be referred by
the GP [11]. Moreover, in another study a structured foot
care programme with early detection of ulcers for patients at
a high-risk of foot ulcers resulted in a reduction in amputa-
tions [12]. A nationwide system for the early detection and
subsequent referral to a specialised diabetic foot team
should therefore be implemented to reduce the amputation
rate. Such a specialised multidisciplinary foot team should
preferably include a diabetologist, vascular surgeon, endo-
vascular specialist, podiatrist, shoe technician and
specialised nurse. Clear guidelines have been formulated
as regards the identification of at-risk patients, diagnosis of
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ment [5]. Several elements of these guidelines have subse-
quently been validated in prospective studies [13–16].
Interestingly, Holman et al [1] observed that amputation
rates in adults with diabetes were correlated with amputation
rates in adults without diabetes (r00.433), pointing to a
common factor. Differences in PAD management might
explain part of the observed geographical variation in both
diabetic and non-diabetic patients. In an earlier study in
England, there was marked variation between vascular sur-
geons in terms of the procedure chosen when given the
choice of amputation or revascularisation in a series of
clinical cases [17]. A recent systematic review reported that
in diabetic patients with critical limb ischaemia who were
not revascularised, the 1 year amputation rate was 57%
compared with a rate of 15–20% in patients who were
revascularised [18]. Moreover, new techniques and technol-
ogies have been introduced for treating PAD; in particular,
endovascular approaches in the lower limb have produced
promising results. If and to what extent differences in PAD
management contribute to the geographical variation in
amputation rate remains to be determined in future studies.
However, each diabetic patient with a (neuro-)ischaemic
foot ulcer should be treated by a multidisciplinary team
that provides the most appropriate and up-to-date thera-
py, i.e. an open (surgical) and/or an endovascular revascu-
larisation procedure.
Although amputation seems a clearly defined endpoint,
there are several caveats in the study by Holman et al [1];
besides those discussed above, there are also methodologi-
cal issues. In reporting amputation rate the following should
be defined in future studies: which amputation in a sequence
is used as the outcome measure (i.e. the first amputation, the
number of amputations or the final amputation level), are
the individuals or are the number of limbs undergoing
amputation reported and are the results based on the number
of hospitalisations. When calculations are based on hospital
admissions, a hospital can be penalised for good clinical
care. For example, an immediate minor amputation can be
indicated in infected neuro-ischaemic ulcers, followed by a
revascularisation procedure once infection is under control.
Subsequently, the patient is treated at home as restoration of
skin microcirculation can take weeks, and is then re-
admitted for a final operation, which can include a second
minor amputation, to produce a foot that remains functional.
In the Holman et al study, two amputations as part of a
planned revascularisation could be interpreted as a worse
outcome than a single major amputation. Moreover, in most
studies, amputations are lumped together. However, a single
toe, a whole forefoot or an above-knee amputation all have a
different impact on quality of life and, in future studies,
amputation levels should be reported. Finally, Holman et
al do not describe the indication, the immediate cause of
amputation or disease severity; these key data should be
included in future studies for interpretation of the data.
Documentation of the geographical variation in amputa-
tion rate within a healthcare system can help to identify
barriers to the access and/or delivery of care that need to
be removed to reduce the incidence of diabetes-related
amputations. But, as discussed above, the amputation rate
is not a good marker of the quality of care, and studies
similar to that reported in the Holman et al paper should
be used as a starting point in a process to improve the
outcome of diabetic foot ulcers. There are four major deci-
sion points in the prevention of an amputation in a patient
with a foot ulcer: early referral to a multidisciplinary team,
aggressive (surgical and medical) management of infection,
diagnosis of PAD with the appropriate tests and revascular-
isation in the case of impaired tissue perfusion. As shown in
the Eurodiale study, even in centres with a specific interest
in the diabetic foot, the standard of care was suboptimal for
many patients, resulting from a lack of clear referral guide-
lines, financial barriers caused by inadequate reimburse-
ment, a lack of availability of staff and the personal beliefs
of the doctors [19]. Treating these ulcers is a challenge for
patients, care givers and healthcare systems. Treatment
should not be focused solely on ulcer healing; diabetic foot
disease is a lifelong condition, which means that the patient
is always at risk of a new ulcer, amputation or early death,
and so a holistic approach is needed to management as well
as prevention.
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